Resources search

Through a 10-month consultative process involving investigators, clinicians, civil society and UN agencies, 20 priority research questions have been identified to address critical knowledge gaps related to clinical management and antiretroviral therapy programme delivery for women and children

This book looks at "...the recent history and the many struggles related to advocacy for access to [antiretroviral] medicines of engaged civil society. Through the experiences of five middle-income countries - Brazil, China, Colombia, India, and Thailand." It presents "...the perspective of local civil society organisations about the national impact of intellectual property protection and access to medications. "These five countries were chosen due to their accumulated experience in this field, their capacity to produce generic medication, their activist efforts, and the exchange of ideas and information that already exists between them"

This animation gives a clear explanation of the benefits of creating a patent pool for HIV medicines. Such a pool would enable drug licence holders to receive a fee while also enabling patents to be accessed by researchers, working on the development of new medicines, and generic manufacturers, which could potentially make newer medicines more affordable to people living in developing countries

This study benchmarks ARV prices of former Soviet Union (FSU) countries against each other and against global and European region ARV prices. The study reveals that extreme price variation exists within and across FSU countries for identical ARVs, which suggests that some countries may be able to obtain ARVs at lower prices and therefore purchase additional ARVs to treat more people

This report documents how the mobilisation around AIDS is driving health systems advancement in China, Dominican Republic, Zimbabwe, Russia, Kenya, India, Cameroon, Zambia and Cambodia, and it highlights the need for improvements in broader systems of care and services to meet the needs of people living with HIV & AIDS and the communities in which they live. It also considers ARV procurement, registration and stock-outs in Argentina, Belize, Cambodia, China, Dominican Republic, India, Malawi, Morocco, Nigeria, Philippines, Russia, Uganda, Zambia, Zimbabwe

This report assesses the quality of antiretroviral medicines obtained at accredited public and private sector antiretroviral procurement and treatment sites in selected African countries. The aim is to help with the development of appropriate quality assurance strategies for antiretrovirals

This report suggests that focus-countries under PEPFAR's Emergency Plan should adopt a standard "preventative care package" as part of their palliative care programmes. It acknowledges that components of the care package are likely to vary within regions and even within countries. The report provides the scientific basis for the interventions that could be included in a preventive care package. Although most of the interventions included are pertinent to both adults and children, HIV-infected/exposed children require additional consideration and a separate document focusing on a preventive care package for such children has been developed

The Horizons Program of the Population Council and the University of Cape Town are conducting a study to identify successful programme strategies in paediatric HIV treatment in South Africa and to determine priority knowledge gaps to be addressed by operations research. This report summarises key findings from the initial consultative workshop of expert practitioners and stake-holders, focusing on the status of providing antiretroviral therapy to children in South Africa and strategies to expand and improve services. It includes providing services to under six year olds

This infopack includes five inserts, which provide background information on antiretroviral therapy (what it is, challenges to implementing safe and effective antiretroviral programmes); antiretroviral therapy (ART) in Ethiopia, including details of where ART is available and eligibility for treatment; general health indicators for Ethiopia, including demography and health service statistics; a statement on the impact of HIV and AIDS in Ethiopia, from societal to community and individual level; and a glossary of words related to HIV and AIDS treatment